Verastem (VSTM) Research & Development (2011 - 2026)

Verastem's Research & Development history runs 16 years deep, the most recent figure standing at $38.2 million for Q1 2026.

• On a quarterly basis, Research & Development rose 31.1% year-over-year to $38.2 million in Q1 2026; TTM through Mar 2026 was $123.7 million, a 33.29% increase from a year earlier, with the FY2025 full-year figure at $114.6 million, up 40.9% from the prior year.
• Research & Development grew to $38.2 million in Q1 2026 per VSTM's latest filing, from $31.7 million in the prior quarter.
• Across five years, Research & Development topped out at $38.2 million in Q1 2026 and bottomed at $10.7 million in Q4 2022.
• The 5-year median for Research & Development is $18.1 million (2024), against an average of $20.4 million.
• Biggest YoY gain for Research & Development was 109.52% in 2023; the steepest drop was 13.4% in 2023.
• Year by year, Research & Development stood at $10.7 million in 2022, then soared by 109.52% to $22.5 million in 2023, then retreated by 7.51% to $20.8 million in 2024, then surged by 52.2% to $31.7 million in 2025, then gained by 20.66% to $38.2 million in 2026.
• Per Business Quant, the three latest VSTM Research & Development figures stand at $38.2 million (Q1 2026), $31.7 million (Q4 2025), and $29.0 million (Q3 2025).